Page last updated: 2024-10-28

fasudil and B16 Melanoma

fasudil has been researched along with B16 Melanoma in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Research Excerpts

ExcerptRelevanceReference
"Fasudil-treated tumors also displayed fewer VM channels."1.42Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo. ( Cai, XY; Chen, J; Fan, JQ; Li, ZY; Ren, JH; Wu, G; Xia, Y; Zhang, LL; Zhang, RG; Zhu, F, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xia, Y1
Cai, XY1
Fan, JQ1
Zhang, LL1
Ren, JH1
Chen, J1
Li, ZY1
Zhang, RG1
Zhu, F1
Wu, G1

Other Studies

1 other study available for fasudil and B16 Melanoma

ArticleYear
Rho Kinase Inhibitor Fasudil Suppresses the Vasculogenic Mimicry of B16 Mouse Melanoma Cells Both In Vitro and In Vivo.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:7

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Blotting, Western; Cell Line, Tumor; Cell Mo

2015